Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects

NCT02470858 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: LDV/SOF+ASV
DRUG: SOF+DCV+SMV
DRUG: SOF+DCV+ASV

Sponsor

Humanity and Health Research Centre

Collaborators

[object Object]
[object Object]